Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00799487 · ClinicalTrials.gov registry record · Phase 4
CONCERTA Lab School Study
A Phase 4 study, sponsored by Ortho-McNeil Janssen Scientific Affairs.
- Completed
- Registry status
- Phase 4
- Development phase
- 89
- Enrollment target
NCT00799487 is a Phase 4 study that has completed, run by Ortho-McNeil Janssen Scientific Affairs. The registered enrollment target is 89 participants.
The verdict
NCT00799487, a Phase 4 study, has completed, sponsored by Ortho-McNeil Janssen Scientific Affairs.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 89 participants
- Enrollment target
Study Summary
The purpose of this trial is to determine if the study medication, CONCERTA (methylphenidate HCl), is safe and effective in improving academic performance and behavior in children with Attention Deficit Hyperactivity Disorder (ADHD) when compared to placebo.
Interventions
- DRUG CONCERTA (methylphenidate HCl) or placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2009-01-02 |
| Est. Completion | 2009-06-26 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00799487
The ClinicalTrials.gov registry entry for NCT00799487 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ortho-McNeil Janssen Scientific Affairs, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CONCERTA (methylphenidate HCl) or placebo is the first listed.
NCT00799487 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00799487 about?
NCT00799487 is a clinical study titled "CONCERTA Lab School Study". The purpose of this trial is to determine if the study medication, CONCERTA (methylphenidate HCl), is safe and effective in improving academic performance and behavior in children with Attention Deficit Hyperactivity Disorder (ADHD) when compared to placebo.
What is the current status of trial NCT00799487?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 89 participants. The study started on 2009-01-02. Estimated completion is 2009-06-26.
What interventions are being tested in trial NCT00799487?
The interventions under investigation include: CONCERTA (methylphenidate HCl) or placebo (DRUG).
Who is sponsoring clinical trial NCT00799487?
This trial is sponsored by Ortho-McNeil Janssen Scientific Affairs, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.